Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein.

Marion S, Urs NM, Peterson SM, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG.

J Biol Chem. 2014 Apr 25;289(17):11715-24. doi: 10.1074/jbc.M113.544312. Epub 2014 Mar 11.

2.

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior.

Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG.

Cell. 2005 Jul 29;122(2):261-73.

3.

Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.

Peterson SM, Pack TF, Wilkins AD, Urs NM, Urban DJ, Bass CE, Lichtarge O, Caron MG.

Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7097-102. doi: 10.1073/pnas.1502742112. Epub 2015 May 11.

4.

Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1.

Espinoza S, Ghisi V, Emanuele M, Leo D, Sukhanov I, Sotnikova TD, Chieregatti E, Gainetdinov RR.

Neuropharmacology. 2015 Jun;93:308-13. doi: 10.1016/j.neuropharm.2015.02.010. Epub 2015 Feb 24.

PMID:
25721394
5.

Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin.

Galan-Rodriguez B, Martin E, Brouillet E, Déglon N, Betuing S, Caboche J.

Eur J Neurosci. 2017 Jan;45(1):198-206. doi: 10.1111/ejn.13415. Epub 2016 Oct 24.

PMID:
27717053
6.
7.

Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.

Charvin D, Vanhoutte P, Pagès C, Borrelli E, Caboche J.

Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12218-23. Epub 2005 Aug 15. Erratum in: Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16530. Borelli, Emiliana [Borrelli, Emilliana].

8.

Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.

Urs NM, Gee SM, Pack TF, McCorvy JD, Evron T, Snyder JC, Yang X, Rodriguiz RM, Borrelli E, Wetsel WC, Jin J, Roth BL, O'Donnell P, Caron MG.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8178-E8186. Epub 2016 Dec 1.

9.

Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.

Harrison LM, Muller SH, Spano D.

Neuroscience. 2013 Apr 16;236:21-30. doi: 10.1016/j.neuroscience.2012.12.062. Epub 2013 Feb 1.

10.

Modulation of A₂a receptor antagonist on D₂ receptor internalization and ERK phosphorylation.

Huang L, Wu DD, Zhang L, Feng LY.

Acta Pharmacol Sin. 2013 Oct;34(10):1292-300. doi: 10.1038/aps.2013.87. Epub 2013 Aug 12.

11.

Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.

Salles MJ, Hervé D, Rivet JM, Longueville S, Millan MJ, Girault JA, Mannoury la Cour C.

J Neurochem. 2013 May;125(4):532-44. doi: 10.1111/jnc.12206. Epub 2013 Mar 11.

12.

Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.

Svenningsson P, Lindskog M, Ledent C, Parmentier M, Greengard P, Fredholm BB, Fisone G.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1856-60.

13.

Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.

Sciamanna G, Napolitano F, Pelosi B, Bonsi P, Vitucci D, Nuzzo T, Punzo D, Ghiglieri V, Ponterio G, Pasqualetti M, Pisani A, Usiello A.

Neurobiol Dis. 2015 Jun;78:146-61. doi: 10.1016/j.nbd.2015.03.021. Epub 2015 Mar 26.

PMID:
25818655
14.

Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.

Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, Greengard P.

Neuroscience. 2006 Jul 7;140(3):897-911.

PMID:
16600521
15.

Amplification of dopaminergic signaling by a positive feedback loop.

Nishi A, Bibb JA, Snyder GL, Higashi H, Nairn AC, Greengard P.

Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12840-5.

16.
17.

Role of G protein-regulated inducer of neurite outgrowth 3 (GRIN3) in β-arrestin 2-Akt signaling and dopaminergic behaviors.

Mototani Y, Okamura T, Goto M, Shimizu Y, Yanobu-Takanashi R, Ito A, Kawamura N, Yagisawa Y, Umeki D, Nariyama M, Suita K, Ohnuki Y, Shiozawa K, Sahara Y, Kozasa T, Saeki Y, Okumura S.

Pflugers Arch. 2018 Mar 2. doi: 10.1007/s00424-018-2124-1. [Epub ahead of print]

PMID:
29500670
18.

Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia.

Radl D, De Mei C, Chen E, Lee H, Borrelli E.

Mol Endocrinol. 2013 Jun;27(6):953-65. doi: 10.1210/me.2013-1008. Epub 2013 Apr 22.

19.

Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.

Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, Caron MG.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13656-61. doi: 10.1073/pnas.0803522105. Epub 2008 Sep 3.

20.

G protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization.

Octeau JC, Schrader JM, Masuho I, Sharma M, Aiudi C, Chen CK, Kovoor A, Celver J.

PLoS One. 2014 Aug 27;9(8):e105791. doi: 10.1371/journal.pone.0105791. eCollection 2014.

Supplemental Content

Support Center